Literature DB >> 25648592

Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: A population-based cohort study of 32,308 one-year survivors.

Thorgerdur Gudmundsdottir1, Jeanette F Winther1, Sofie de Fine Licht1, Trine G Bonnesen2, Peter H Asdahl2, Laufey Tryggvadottir3,4, Harald Anderson5, Finn Wesenberg6,7,8, Nea Malila9, Henrik Hasle2, Jørgen H Olsen1.   

Abstract

The lifetime risk for cardiovascular disease in a large cohort of childhood cancer survivors has not been fully assessed. In a retrospective population-based cohort study predicated on comprehensive national health registers, we identified a cohort of 32,308 one-year survivors of cancer diagnosed before the age of 20 in the five Nordic countries between the start of cancer registration in the 1940s and 1950s to 2008; 211,489 population comparison subjects were selected from national population registers. Study subjects were linked to national hospital registers, and the observed numbers of first hospital admission for cardiovascular disease among survivors were compared with the expected numbers derived from the population comparison cohort. Cardiovascular disease was diagnosed in 2,632 childhood cancer survivors (8.1%), yielding a standardized hospitalization rate ratio (RR) of 2.1 (95% CI 2.0-2.2) and an overall absolute excess risk (AER) of 324 per 100,000 person-years. At the end of follow-up 12% of the survivors were ≥ 50 years of age and 4.5% ≥ 60 years of age. Risk estimates were significantly increased throughout life, with an AER of ∼500-600 per 100,000 person-years at age ≥ 40. The highest relative risks were seen for heart failure (RR, 5.2; 95% CI 4.5-5.9), valvular dysfunction (4.6; 3.8-5.5) and cerebrovascular diseases (3.7; 3.4-4.1). Survivors of hepatic tumor, Hodgkin lymphoma and leukemia had the highest overall risks for cardiovascular disease, although each main type of childhood cancer had increased risk with different risk profiles. Nordic childhood cancer survivors are at markedly increased risk for cardiovascular disorders throughout life. These findings indicate the need for preventive interventions and continuous follow-up for this rapidly growing population.
© 2015 UICC.

Entities:  

Keywords:  cardiovascular disease; childhood cancer; clinical epidemiology; hospitalizations; late complications

Mesh:

Year:  2015        PMID: 25648592     DOI: 10.1002/ijc.29468

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.

Authors:  Line Kenborg; Jeanette Falck Winther; Karen Markussen Linnet; Anja Krøyer; Vanna Albieri; Anna Sällfors Holmqvist; Laufey Tryggvadottir; Laura Maria Madanat-Harjuoja; Marilyn Stovall; Henrik Hasle; Jørgen H Olsen
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

2.  Measuring childhood cancer late effects: evidence of a healthy survivor effect.

Authors:  Peter Haubjerg Asdahl; Rohit Priyadarshi Ojha; Jeanette Falck Winther; Anna Sällfors Holmqvist; Sofie de Fine Licht; Thorgerdur Gudmundsdottir; Laura Madanat-Harjuoja; Laufey Tryggvadottir; Klaus Kaae Andersen; Henrik Hasle
Journal:  Eur J Epidemiol       Date:  2017-11-28       Impact factor: 8.082

3.  Noncancer mortality among adolescents and young adults with cancer.

Authors:  Chelsea Anderson; Jennifer L Lund; Mark A Weaver; William A Wood; Andrew F Olshan; Hazel B Nichols
Journal:  Cancer       Date:  2019-03-20       Impact factor: 6.860

4.  Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer Survivors.

Authors:  Amy M Berkman; Abenaa M Brewster; Lee W Jones; Jun Yu; J Jack Lee; S Andrew Peng; Abigail Crocker; Joann L Ater; Susan C Gilchrist
Journal:  J Adolesc Young Adult Oncol       Date:  2017-05-22       Impact factor: 2.223

5.  Long-Term Risk of Hospitalization Among Five-Year Survivors of Childhood Leukemia in the Nordic Countries.

Authors:  Gitte Vrelits Sørensen; Jeanette Falck Winther; Sofie de Fine Licht; Klaus Kaa Andersen; Anna Sällfors Holmqvist; Laura Madanat-Harjuoja; Laufey Tryggvadottir; Andrea Bautz; Timothy L Lash; Henrik Hasle
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

6.  Multimorbidity patterns and risk of hospitalisation in children: A population cohort study of 3.6 million children in England, with illustrative examples from childhood cancer survivors.

Authors:  Sheng-Chia Chung; Stefanie Mueller; Katherine Green; Wai Hoong Chang; Darren Hargrave; Alvina G Lai
Journal:  Lancet Reg Health Eur       Date:  2022-06-30

Review 7.  Cardio-toxicity in childhood cancer survivors "Cure is not enough".

Authors:  Ulrich Neudorf; Anne Schönecker; Dirk Reinhardt
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 8.  Cellular senescence in aging and age-related disease: from mechanisms to therapy.

Authors:  Bennett G Childs; Matej Durik; Darren J Baker; Jan M van Deursen
Journal:  Nat Med       Date:  2015-12       Impact factor: 53.440

9.  Hospitalization and mortality outcomes in the first 5 years after a childhood cancer diagnosis: a population-based study.

Authors:  Angela Steineck; Eric J Chow; David R Doody; Beth A Mueller
Journal:  Cancer Causes Control       Date:  2021-04-09       Impact factor: 2.532

10.  Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin's lymphoma survivors.

Authors:  Krista Ocier; Sarah Abdelaziz; Seungmin Kim; Kerry Rowe; John Snyder; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Christina A Porucznik; Kimberley Shoaf; Joseph B Stanford; Catherine J Lee; Mia Hashibe
Journal:  Cancer Med       Date:  2021-05-12       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.